S. Banks

Destruction of WiDr multicellular tumor spheroids with the novel thymidylate synthase inhibitor 1843U89 at physiological thymidine concentrations

Gary K. Smith, S. Dickerson, W. Pendergast, 2004, Cancer Chemotherapy and Pharmacology.

Toward Antibody-directed Enzyme Prodrug Therapy with the T268G Mutant of Human Carboxypeptidase A1 and Novel in VivoStable Prodrugs of Methotrexate*

John Miller, J. Humphreys, T. Blumenkopf, 1997, The Journal of Biological Chemistry.

Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal tissue, neoplastic cells, and oncogene-transformed cells.

R. Rigual, T. Monaco, R. Mullin, 1990, Archives of biochemistry and biophysics.

On the substrate specificity of bovine liver dihydrofolate reductase: new unconjugated dihydropterin substrates.

E. Bigham, G. K. Smith, C. A. Nichol, 1987, Archives of biochemistry and biophysics.

Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.

R. Ferone, J. Humphreys, Gary K. Smith, 1993, Cancer research.